Browse studies
Find your next paid study
4 recruiting studies matching your filters
Phase 2
A Single-arm Open-label Study Assessing Efficacy of Bimekizumab in Adult Participants With Pyoderma Gangrenosum Over 24 Weeks
The purpose of the study is to learn more about an experimental drug bimekizumab that may be helpful for Pyoderma Gangrenosum (PG). Bimekizumab will be referre…
Pyoderma Gangrenosum
Estimated
~$10 – $6,250
Oregon Health and Science UniversityNCT07767864
Phase 3
A Multi-centre, Randomised, Placebo-controlled, Double-blind, Parallel-group Trial to Evaluate Safety and Efficacy of Spesolimab (BI 655130) in Adult Patients With Ulcerative Pyoderma Gangrenosum (PG) Who Require Systemic Therapy
The purpose of this study is to find out whether a medicine called spesolimab helps people with pyoderma gangrenosum (PG). The main aim is to see whether speso…
Pyoderma Gangrenosum
Estimated
~$10 – $8,750
LEO PharmaNCT06624670
A Longitudinal, Real World, Observational Registry of Chronic Wounds and Ulcers and the Patients Who Have Them
WOUNDJOURNEY is a longitudinal, real-world, observational registry designed to capture the full clinical course and patient journey associated with chronic wou…
Diabetic FootPressure UlcerSurgical Wound Dehiscence+17 more
Estimated
~$10 – $1,125
U.S. Wound RegistryNCT02280733
Phase 2
A Single-arm Open-label Study Assessing Short-term (Week 6, 16) and Long-term (Week 32) Efficacy of Guselkumab in Adult Participants With Pyoderma Gangrenosum
A single-arm open-label study assessing short-term (week 6, 16) and long-term (week 32) efficacy of guselkumab in adult participants with pyoderma gangrenosum …
Pyoderma GangrenosumSkin DiseasesWound Heal+2 more
Estimated
~$10 – $6,250
Oregon Health and Science UniversityNCT06563323